Cargando…
Patent foramen ovale and atrial fibrillation as causes of cryptogenic stroke: is treatment with surgery superior to device closure and anticoagulation? A review of the literature
Closure of persistent foramen ovale (PFO) to avoid cryptogenic strokes is performed globally with enthusiasm but lacks prove of efficacy. We present a 79-year-old man who had had a PFO device introduced nine years previously because of cryptogenic strokes presenting as syncopes. The patient was refe...
Autores principales: | Kjeld, Thomas, Jørgensen, Tem S, Fornitz, Gitte, Roland, Jan, Arendrup, Henrik C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109859/ https://www.ncbi.nlm.nih.gov/pubmed/30159163 http://dx.doi.org/10.1177/2058460118793922 |
Ejemplares similares
-
Monitoring for atrial fibrillation prior to patent foramen ovale
closure after cryptogenic stroke
por: Diener, Hans-Christoph, et al.
Publicado: (2022) -
Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017) -
Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019) -
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
por: Mir, Hassan, et al.
Publicado: (2018) -
Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure: protocol for the prospective, observational PFO-AF study
por: Badoz, Marc, et al.
Publicado: (2023)